Jasper Therapeutics (JSPR) Current Taxes (2019 - 2020)
Jasper Therapeutics (JSPR) posted Current Taxes of $7913.0 for Q3 2020, down 89.14% on a QoQ basis from $72853.0 in Q2 2020.
Powered by 
Analysis
Jasper Therapeutics (JSPR) Current Taxes (2019 - 2020) Analysis & Trends
Jasper Therapeutics has reported Current Taxes for 2 years, with the latest figure at $7913.0 in Q3 2020.
- On a quarterly basis, Current Taxes changed N/A year-over-year to $7913.0 in Q3 2020; TTM through Sep 2020 was $7913.0, a N/A change from a year earlier, with the FY2019 full-year figure at $16225.0, changed N/A from the prior year.
- Current Taxes was $7913.0 for Q3 2020 at Jasper Therapeutics, down from $72853.0 in the prior quarter.
- The five-year high for Current Taxes was $74048.0 in Q1 2020, with the low at $7913.0 in Q3 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 49.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 86.90 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 74.18 Mn |
| 10 | Jasper Therapeutics | 20.11 Mn | 20.11 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | 7,913.00 |
| Jun 30, 2020 | 72,853.00 |
| Mar 31, 2020 | 74,048.00 |
| Dec 31, 2019 | 16,225.00 |